✦ LIBER ✦

One-year experience with agalsidase alfa in a patient with Fabry disease on peritoneal dialysis

✍ Scribed by C Spisni; R Di Vito; A Stingone; S Stuard; B D'angelo; L Caravelli; M Mascitti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of agalsidase alfa in patients wi

✍ U Ramaswami; R Parini; C Kampmann; M Beck 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Four-Year Prospective Clinical Trial of

✍ Raphael Schiffmann; Rick A. Martin; Tyler Reimschisel; Karen Johnson; Victoria C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Successful pregnancy outcome in a patien

✍ S. Wendt; C. Whybra; C. Kampmann; E. Teichmann; M. Beck 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 83 KB

Evaluation of Plasma Globotriaosylsphing

✍ Charles Lourenco; Janice Coelho; Miguel Moyses Neto; Osvaldo Merege Vieira Neto; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effects of enzyme replacement therapy wi

✍ F Dehout; A Schwarting; M Beck; A Mehta; R Ricci; U Widmer; on behalf of the FOS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Patients with Fabry disease on dialysis

✍ Thadhani, Ravi; Wolf, Myles; West, Michael L.; Tonelli, Marcello; Ruthazer, Robi 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 242 KB